ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster

Ekaterina Migunova, Joanna Theophilopoulos, Marisa Mercadante, Jing Men, Chao Zhou, Edward B. Dubrovsky

Research output: Contribution to journalArticlepeer-review


A severe form of infantile cardiomyopathy (CM) has been linked to mutations in ELAC2, a highly conserved human gene. It encodes Zinc phosphodiesterase ELAC protein 2 (ELAC2), which plays an essential role in the production of mature tRNAs. To establish a causal connection between ELAC2 variants and CM, here we used the Drosophila melanogaster model organism, which carries the ELAC2 homolog RNaseZ. Even though RNaseZ and ELAC2 have diverged in some of their biological functions, our study demonstrates the use of the fly model to study the mechanism of ELAC2-related pathology. We established transgenic lines harboring RNaseZ with CM-linked mutations in the background of endogenous RNaseZ knockout. Importantly, we found that the phenotype of these flies is consistent with the pathological features in human patients. Specifically, expression of CM-linked variants in flies caused heart hypertrophy and led to reduction in cardiac contractility associated with a rare form of CM. This study provides first experimental evidence for the pathogenicity of CM-causing mutations in the ELAC2 protein, and the foundation to improve our understanding and diagnosis of this rare infantile disease.

Original languageEnglish
Article numberdmm049509
JournalDMM Disease Models and Mechanisms
Issue number3
StatePublished - Mar 2022


  • Cardiomyopathy
  • Drosophila
  • ELAC2
  • OCM
  • RNase Z


Dive into the research topics of 'ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster'. Together they form a unique fingerprint.

Cite this